Cellectar Biosciences, Inc. (NASDAQ:CLRB) shares are gapping higher 1.56% pre-market with a price of $1.91 on the stock. Investors will be keeping a close eye on the stock during this session to see if the upward trend will remain throughout the day.
Successfully tackling the equity markets may involve owning a wide range of stocks. Some investors may prefer growth stocks while others may opt for value stocks. Having a good mix of both types may help build of solid foundation for the portfolio. Investors may choose stocks in a specific industry that is gaining strength. If the industry is on the rise, the portfolio may be more likely to succeed. Finding companies that are considered leaders in their field may also be on the investor checklist. A company that has a large presence may help ease investor worry, especially in a down market climate. Finding the perfect stocks to add to the portfolio may not always be easy, and in fact it may be quite difficult. Investors may have to lay out goals to help keep things on track for both the short-term and the long haul.
The consensus analysts recommendation at this point stands at 1.00 for Cellectar Biosciences, Inc.. This is based on a 1-5 scale where 1 indicates a Strong Buy and 5 a Strong Sell. Further, analysts have a 12 month target price of $3.10 on company shares. This is according to the analysts polled by Thomson Reuters which have recently published research reports on the firm.
The equity stands -37.79% away from the 52-week high and 70.54% from the 52-week low. The RSI (Relative Strength Index), an indicator that shows price strength by comparing upward and downward close-to-close movements is 64.82.
With the recent move, the stock now boasts a market cap of 26.42and a beta of 1.01.
Will shares of Ekso Bionics Holdings, Inc. (:EKSO) hold onto their early gains? The stock is gapping up 1.67% before market open touching $1.17 on a recent bid.
At the time of writing, the stock was trading at $1.17. This represents a change from the opening price of -4.10%. In terms of performance, year to date, the stock is -69.85%. The monthly stock performance comes in at -5.51%. For the quarter, shares are performing at -44.19%. Weekly performance analysis shows the equity at -2.44%.
In taking a look at technical levels, shares are trading -13.76% away from the 50 day simple moving average and -52.97% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -81.66% away from it’s 52- week high and 18.18% away from its 52 week low.
As of writing, Ekso Bionics Holdings, Inc.’s RSI stands at 41.37. In looking at volatility levels, the shares saw weekly volatility of 7.41% and 8.27% over the past month.